REGENEREX PHARMA, INC. Annual Operating Income (Loss) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Regenerex Pharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2023.
  • Regenerex Pharma, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$258K, a 90.7% increase year-over-year.
  • Regenerex Pharma, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$1.03M, a 65.6% increase year-over-year.
  • Regenerex Pharma, Inc. annual Operating Income (Loss) for 2023 was -$3.47M, a 3504% decline from 2022.
  • Regenerex Pharma, Inc. annual Operating Income (Loss) for 2022 was -$96.2K, a 23.8% increase from 2021.
  • Regenerex Pharma, Inc. annual Operating Income (Loss) for 2021 was -$126K, a 191% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$3.47M -$3.37M -3504% Apr 1, 2023 Mar 31, 2024 10-K 2024-06-24
2022 -$96.2K +$30.1K +23.8% Apr 1, 2022 Mar 31, 2023 10-K 2024-06-24
2021 -$126K -$82.9K -191% Apr 1, 2021 Mar 31, 2022 10-K 2023-06-09
2020 -$43.4K +$33.6K +43.6% Apr 1, 2020 Mar 31, 2021 10-K 2022-06-28
2019 -$77K +$14.7K +16.1% Apr 1, 2019 Mar 31, 2020 10-K 2021-06-23
2018 -$91.7K -$42.3K -85.5% Apr 1, 2018 Mar 31, 2019 10-K/A 2020-08-11
2017 -$49.5K -$46.9K -1822% Apr 1, 2017 Mar 31, 2018 10-K 2019-06-24
2016 -$2.57K Apr 1, 2016 Mar 31, 2017 10-K 2018-06-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.